Africa: making the case against counterfeit drugs at LEEM-sponsored meeting

8 February 2010

The fight against fake and counterfeit medicines requires a united public-private front to overcome people's resistance to health warnings and to dismantle increasingly sophisticated trafficking networks, medical professionals said at a meeting in the Togolese capital Lome, reports the United Nations Integrated Regional Information Networks (IRIN).

The counterfeit medicines industry thrives because the products sell well, despite health warnings, sub-Saharan Africa health officials said at a January 27-28 meeting aimed at reinforcing public and private efforts against fake drugs organized by LEEM, a trade body representing French pharmaceutical companies, which brought together government health officials from francophone African countries.

"Some people scoff at those who advise against street medicines," Sophie Bipolo, national pharmaceutical director in Gabon, told IRIN. "People say we denounce those medicines because we are in competition with them, but unfortunately people do not realize the dangers these products pose to their health," she added.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight





More Features in Pharmaceutical